These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 452502)

  • 1. [Physiological activity of kappa-casein glycomacropeptide].
    Stan EIa; Chernikov MP
    Vopr Med Khim; 1979; 25(3):348-52. PubMed ID: 452502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Heterogeneity of the kappa-casein glycomacropeptide and physiological activity of its fractions].
    Chernikov MP; Stan EIa; Vasilevskaia LS; Shlygin GK
    Vopr Pitan; 1979; (5):22-6. PubMed ID: 516596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of kappa-casein glycomacropeptide on gastrointestinal motility in dogs].
    Stan EIa; Groĭsman SD; Krasil'shchikov KB; Chernikov MP
    Biull Eksp Biol Med; 1983 Jul; 96(7):10-2. PubMed ID: 6871439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Glycopeptide obtained from k-casein and its effect on protein assimilation].
    Aleĭnik SI; Stan EIa; Chernikov MP
    Vopr Pitan; 1984; (2):47-50. PubMed ID: 6741020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of a parenterally administered casein hydrolysate on the secretory activity of the stomach with different degrees of gastric gland denervation].
    Vasilevskaia LS; Klimashina TA; Laktaeva TV
    Vopr Pitan; 1977; (1):41-4. PubMed ID: 407721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of a glycomacropeptide of kappa-casein as a substrate for neuraminidase].
    Chernova IA; Shataeva LK; Abrashev I; Velcheva P; Samsonov GV
    Vopr Med Khim; 1987; 33(3):53-5. PubMed ID: 3630016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanism of inhibition of acid secretion into the stomach by peptides of kappa-casein].
    Aleĭnik SI; Stan EIa; Chernikov MP
    Fiziol Zh SSSR Im I M Sechenova; 1986 Jun; 72(6):799-803. PubMed ID: 3732556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Action of secretin on the gastric secretion induced by food stimuli, pentagastrin, histamine and the parenteral administration of casein hydrolysate].
    Vasilevskaia LS; Klimashina TA
    Vopr Pitan; 1979; (2):49-53. PubMed ID: 107652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemical composition of casein glycomacropeptide components].
    Varsanovich EA; Usacheva NT; Stan EIa; Vasil'ev AV; Chernikov MP
    Vopr Med Khim; 1976; 22(5):648-52. PubMed ID: 1014475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibition of the motility of the gastrointestinal tract by low-molecular peptides from k-casein].
    Groĭsman SD; Gubkin VA; STan EIa
    Biull Eksp Biol Med; 1987 Oct; 104(10):423-6. PubMed ID: 3676458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Physiologically active peptides from kappa-casein].
    Stan EIa; Aleĭnik SI; Chernikov MP
    Fiziol Zh SSSR Im I M Sechenova; 1983 Jun; 69(6):855-8. PubMed ID: 6873396
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anti-gastrin effect of glycomacropeptide].
    Shlygin GK; Vasilevskaia LS; Chernikov MP; Nikol'skaia GV
    Biull Eksp Biol Med; 1971 Dec; 72(12):9-13. PubMed ID: 5132147
    [No Abstract]   [Full Text] [Related]  

  • 13. [The role of the adenylate cyclase system in the inhibition of gastric secretion by products of limited hydrolysis of kappa-casein].
    Aleĭnik SI; Stan EIa; Chernikov MP
    Biull Eksp Biol Med; 1987 Apr; 103(4):390-2. PubMed ID: 3032297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nature of the stimulating action of parenterally administered casein hydrolysate on gastric secretory function].
    Sysoev IuA; Kremer IuN; Shlygin GK
    Vopr Pitan; 1982; (2):31-5. PubMed ID: 6806982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition by lactoferrin and kappa-casein glycomacropeptide of binding of Cholera toxin to its receptor.
    Kawasaki Y; Isoda H; Tanimoto M; Dosako S; Idota T; Ahiko K
    Biosci Biotechnol Biochem; 1992 Feb; 56(2):195-8. PubMed ID: 1368296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of kappa-casien glycomacropeptide from sweet whey with undetectable level of phenylalanine.
    Nakano T; Silva-Hernandez ER; Ikawa N; Ozimek L
    Biotechnol Prog; 2002; 18(2):409-12. PubMed ID: 11934315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycomacropeptide and alpha-lactalbumin supplementation of infant formula affects growth and nutritional status in infant rhesus monkeys.
    Kelleher SL; Chatterton D; Nielsen K; Lönnerdal B
    Am J Clin Nutr; 2003 May; 77(5):1261-8. PubMed ID: 12716681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Several new inhibitors of gastric secretion].
    Vasilevskaia LS
    Fiziol Zh SSSR Im I M Sechenova; 1978 Jun; 64(6):871-5. PubMed ID: 28254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological activities of bovine glycomacropeptide.
    Brody EP
    Br J Nutr; 2000 Nov; 84 Suppl 1():S39-46. PubMed ID: 11242445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Isolation, amino acid composition and type of action of gastric secretion inhibitors derived from k-casein].
    Stan EIa; Ekimovskiĭ AP; Aleĭnik SI; Vasilevskaia LS; Chernikov MP
    Vopr Med Khim; 1986; 32(5):98-102. PubMed ID: 3776123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.